Report Detail

Pharma & Healthcare IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review

  • RnM2975597
  • |
  • 18 February, 2019
  • |
  • Global
  • |
  • 59 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commercialization and technologies, and helps stimulate significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behaviors and scientific advances. IQVIA serves biotech, medical device and pharmaceutical companies; medical researchers, government agencies, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, the Middle East and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc Key Recent Developments

Feb 04,2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Jan 31,2019: IQVIA Launches Next Generation Site Portal Technology Capabilities to Streamline Clinical Trial ...
Jan 30,2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
Jan 19,2019: Iqvia launches new division to support emerging biotech market

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents

    Table of Contents

      List of Tables

        List of Figures

          Section 1 - About the Company

            IQVIA Holdings Inc - Key Facts

              IQVIA Holdings Inc - Key Employees

                IQVIA Holdings Inc - Key Employee Biographies

                  IQVIA Holdings Inc - Major Products and Services

                    IQVIA Holdings Inc - History

                      IQVIA Holdings Inc - Company Statement

                        IQVIA Holdings Inc - Locations And Subsidiaries

                          Head Office

                            Other Locations & Subsidiaries

                              Joint Venture

                                Section 2 – Company Analysis

                                  Company Overview

                                    IQVIA Holdings Inc - Business Description

                                      Business Segment: Commercial Solutions

                                        Overview

                                          Performance

                                            Business Segment: Integrated Engagement Services

                                              Overview

                                                Performance

                                                  Business Segment: Research & Development Solutions

                                                    Overview

                                                      Performance

                                                        Geographical Segment: Americas

                                                          Performance

                                                            Geographical Segment: Asia-Pacific

                                                              Performance

                                                                Geographical Segment: Europe and Africa

                                                                  Performance

                                                                    IQVIA Holdings Inc - Corporate Strategy

                                                                      IQVIA Holdings Inc - SWOT Analysis

                                                                        SWOT Analysis - Overview

                                                                          IQVIA Holdings Inc - Strengths

                                                                            IQVIA Holdings Inc - Weaknesses

                                                                              IQVIA Holdings Inc - Opportunities

                                                                                IQVIA Holdings Inc - Threats

                                                                                  IQVIA Holdings Inc - Key Competitors

                                                                                    Section 3 – Company Financial Ratios

                                                                                      Financial Ratios - Capital Market Ratios

                                                                                        Financial Ratios - Annual Ratios

                                                                                          Performance Chart

                                                                                            Financial Performance

                                                                                              Financial Ratios - Interim Ratios

                                                                                                Financial Ratios - Ratio Charts

                                                                                                  Section 4 – Company’s Lifesciences Financial Deals and Alliances

                                                                                                    IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

                                                                                                      IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

                                                                                                        IQVIA Holdings Inc, Recent Deals Summary

                                                                                                          Section 5 – Company’s Recent Developments

                                                                                                            Feb 04, 2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

                                                                                                              Feb 04, 2019: IQVIA launches IQVIA Biotech, dedicated to emerging biotech and biopharma industry

                                                                                                                Jan 30, 2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019

                                                                                                                  Dec 06, 2018: IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards

                                                                                                                    Nov 29, 2018: IQVIA s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency

                                                                                                                      Nov 27, 2018: IQVIA s orchestrated customer engagement selected by Novo Nordisk international operations

                                                                                                                        Nov 27, 2018: IQVIAs orchestrated customer engagement selected by Novo Nordisk international operations

                                                                                                                          Nov 20, 2018: Adhera Therapeutics selects IQVIA’s OCE technology platform to support commercial excellence

                                                                                                                            Oct 30, 2018: Public Release: 30-Oct-2018 Life-changing intersection between big data and therapeutic pipeline in neuromuscular disease MWW Group A new report funded by the Muscular Dystrophy Association (MDA) and released by the IQVIA Institute for Human Data Science

                                                                                                                              Oct 18, 2018: Xeloda Adherence Support App Contributes to Improving Communication between Cancer Patients and Healthcare Providers

                                                                                                                                Section 6 – Appendix

                                                                                                                                  Methodology

                                                                                                                                    Ratio Definitions

                                                                                                                                      About GlobalData

                                                                                                                                        Contact Us

                                                                                                                                          Disclaimer

                                                                                                                                          Summary:
                                                                                                                                          Get latest Market Research Reports on IQVIA Holdings Inc (IQV) . Industry analysis & Market Report on IQVIA Holdings Inc (IQV) is a syndicated market report, published as IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review. It is complete Research Study and Industry Analysis of IQVIA Holdings Inc (IQV) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                                          Last updated on

                                                                                                                                          REPORT YOU MIGHT BE INTERESTED

                                                                                                                                          Purchase this Report

                                                                                                                                          $500.00
                                                                                                                                          $1,000.00
                                                                                                                                          $1,500.00
                                                                                                                                          393.00
                                                                                                                                          786.00
                                                                                                                                          1,179.00
                                                                                                                                          461.50
                                                                                                                                          923.00
                                                                                                                                          1,384.50
                                                                                                                                          78,420.00
                                                                                                                                          156,840.00
                                                                                                                                          235,260.00
                                                                                                                                          41,675.00
                                                                                                                                          83,350.00
                                                                                                                                          125,025.00
                                                                                                                                          Credit card Logo

                                                                                                                                          Related Reports


                                                                                                                                          Reason to Buy

                                                                                                                                          Request for Sample of this report